Levorová Jitka, Machoň Vladimír, Grill Pavel, Hirjak Dušan, Foltán René
Department of Dental Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
Prague Med Rep. 2015;116(4):303-13. doi: 10.14712/23362936.2015.69.
Keratocystic odontogenic tumour is relatively rare benign tumour. It is characterized by its fast aggressive growth and high risk of recurrence. Treatment is always surgical: conservative (enucleation, marsupialization) or aggressive (enucleation followed by application of Carnoy's solution, cryotherapy; peripheral ostectomy or en block resection of the jaw). Authors analysed retrospectively 22 patients who fulfilled inclusion criteria, i.e. had odontogenic keratocystic tumour of mandible, wherein antero-posterior dimension was at least 30 mm, and the tumour penetrated into the surrounding soft tissues. All patients underwent tumour enucleation, in 11 patients Carnoy's solution was given into the bone cavity after enucleation. The recurrence rate in the evaluation at least 36 months after surgery was both patient groups the same: 45.4%.
牙源性角化囊性瘤是一种相对罕见的良性肿瘤。其特点是生长迅速且侵袭性强,复发风险高。治疗通常采用手术方式:保守治疗(摘除术、袋形术)或积极治疗(摘除术后应用卡诺氏液、冷冻疗法;周边骨切除术或下颌骨整块切除术)。作者回顾性分析了22例符合纳入标准的患者,即患有下颌骨牙源性角化囊性瘤,其前后径至少为30毫米,且肿瘤已侵入周围软组织。所有患者均接受了肿瘤摘除术,其中11例患者在摘除术后将卡诺氏液注入骨腔。两组患者术后至少36个月的评估复发率相同:均为45.4%。